[1] Picardeau M. Virulence of the zoonotic agent of leptospirosis: still terra incognita[J]. Nat Rev Microbiol, 2017,15(5):297-307. [2] Bertelloni F, Cilia G, Turchi B, et al. Epidemiology of leptospirosis in North-Central Italy: fifteen years of serological data (2002-2016)[J].Comp Immunol Microbiol Infect Dis, 2019, 65(1):14-22. [3] Abela-Ridder B, Sikkema R, Hartskeerl RA. Estimating the burden of human leptospirosis[J]. Int J Antimicrob Agents, 2010, 36 (Suppl 1):S5-7. [4] Guernier V, Richard V, Nhan T, et al. Leptospira diversity in animals and humans in Tahiti, French Polynesia[J]. PLoS Negl Trop Dis, 2017,11(6):e0005676. [5] Xu Y, Zhu Y, Wang Ye, et al. Whole genome sequencing revealed host adaptation-focused genomic plasticity of pathogenic Leptospira[J]. Sci Rep, 2016, 6:20020. [6] Fouts DE,Matthias MA,Adhikarla H, et al. What makes a bacterial species pathogenic? Comparative genomic analysis of the genus Leptospira[J]. PLoS Negl Trop Dis, 2016,10(2):e0004403. [7] Siriphan B, Janjira T, Premjit A, et al. A single multilocus sequence typing (MLST) scheme for seven pathogenic Leptospira species[J]. PLoS Negl Trop Dis, 2013, 7(1):e1954. [8] Weiss S, Menezes A, Woods K, et al. An extended multilocus sequence typing (MLST) scheme for rapid direct typing of Leptospira from clinical samples[J].PLoS Negl Trop Dis, 2016, 10(9):e0004996. [9] Vincent AT, Schiettekatte O, Goarant C,et al. Revisiting the taxonomy and evolution of pathogenicity of the genus Leptospira through the prism of genomics[J]. PLoS Negl Trop Dis, 2019,13(5):e0007270.
2020, Vol. 27 
